Mervis CB, Morris CA. Williams syndrome. Neurogenetic developmental disorders: Variation of manifestation in childhood 2007:199–262.

Morris CA. Introduction: Williams syndrome. Am J Med Genet C Semin Med Genet. 2010;154C(2):203–8.

Article  PubMed  PubMed Central  Google Scholar 

Sugayama SMM, Koch VHK, Furusawa ÉA, Leone C, Kim CA. Renal and urinary findings in 20 patients with Williams-Beuren syndrome diagnosed by fluorescence in situ hybridization (FISH). Revista do Hospital das Clínicas. 2004;59(5):266–72.

Article  PubMed  Google Scholar 

Stanley TL, Leong A, Pober BR. Growth, body composition, and endocrine issues in Williams syndrome. Curr Opin Endocrinol Diabetes Obes. 2021;28(1):64–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bastug F, Nalcacioglu H, Bas VN, Tekatli-Celik B, Cetinkaya H, Yel S. Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome. Turk J Pediatr. 2018;60(2):210–5.

Article  PubMed  Google Scholar 

Pober BR, Lacro RV, Rice C, Mandell V, Teele RL. Renal findings in 40 individuals with Williams syndrome. Am J Med Genet. 1993;46(3):271–4.

Article  CAS  PubMed  Google Scholar 

Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629–37.

Article  PubMed  PubMed Central  Google Scholar 

Sanjad SA, Aoun B, Yammine H, Bassyouni A, Karam PE. Pamidronate rescue therapy for hypercalcemia in a child with williams syndrome. Front Endocrinol (Lausanne). 2018;9:240.

Article  PubMed  Google Scholar 

Gupta V, Pandita A, Panghal A, Kallem VR. Williams syndrome with severe hypercalcaemia. BMJ Case Rep 2018.

Sangun O, Dundar BN, Erdogan E. Severe hypercalcemia associated with Williams syndrome successfully treated with pamidronate infusion therapy. J Pediatr Endocrinol Metab. 2011;24(1–2):69–70.

PubMed  Google Scholar 

Cagle AP, Waguespack SG, Buckingham BA, Shankar RR, Dimeglio LA. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate. Pediatrics. 2004;114(4):1091–5.

Article  PubMed  Google Scholar 

Oliveri B, Mastaglia SR, Mautalen C, Gravano JC, Pardo AL. Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate). Acta Paediatr. 2004;93(7):1002–3.

Article  CAS  PubMed  Google Scholar 

Ismail J. Pamidronate for long-term control of hypercalcemia associated with Williams syndrome. Indian Pediatr. 2015;52(2):163–4.

PubMed  Google Scholar 

Bhat NA, Mustafa F, Sheikh RY, Wani I. Incidence, etiology, and course of hypercalcemia-induced AKI in a tertiary care center from northern India. Egyptian J Int Med. 2021;33(1):36.

Article  Google Scholar 

Rauch F, Travers R, Plotkin H, Glorieux FH. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Investig. 2002;110(9):1293. https://doi.org/10.1172/JCI15952.

Article  CAS  PubMed  PubMed Central  Google Scholar